Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrea Pakula

Surgery Thousand Oaks, CA Medical Doctor

NPI 1568767960 CMS profile 607158

77 Rolling Oaks Dr, Ste 203, Thousand Oaks, CA 91361

Open in the dashboard

General payments

$1,401,006

1,539 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Andrea Pakula of Thousand Oaks, CA is reported in the CMS Open Payments database as having received $1,401,006 across 1,539 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $264,648 234
2024 General $300,041 302
2023 General $235,549 254
2022 General $263,356 317
2021 General $139,621 169
2020 General $88,311 95
2019 General $109,482 168

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrea Pakula
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Andrea Pakula were reported at $264,648. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Andrea Pakula Surgery median Middle half National median
2019 $109,482 $253 $82–$1,521 $163
2020 $88,311 $131 $40–$706 $114
2021 $139,621 $168 $50–$904 $132
2022 $263,356 $224 $76–$1,218 $149
2023 $235,549 $253 $82–$1,255 $160
2024 $300,041 $279 $90–$1,381 $164
2025 $264,648 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $1,255,299 1,307 payments
  2. Davol Inc. $110,670 144 payments
  3. Medtronic, Inc. $32,396 54 payments
  4. C. R. Bard, Inc. & Subsidiaries $1,169 7 payments
  5. TELA Bio, Inc. $537 6 payments
  6. CONMED Corporation $444 6 payments
  7. Osiris Therapeutics Inc. $123 2 payments
  8. Covidien LP $119 1 payment
  9. Baxter Healthcare $60 3 payments
  10. Myriad Genetic Laboratories, Inc. $38 2 payments
  11. Other $151 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $597,860 227 payments
  2. Education $563,193 343 payments
  3. Honoraria $89,460 25 payments
  4. Travel and Lodging $85,384 430 payments
  5. Food and Beverage $44,740 492 payments
  6. Consulting Fee $19,985 14 payments
  7. Gift $384 8 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $1,107,649 1,243 payments
  2. DA VINCI SP $144,650 63 payments
  3. PHASIX Davol $27,311 58 payments
  4. ProGrip $11,058 40 payments
  5. Dextile $10,745 6 payments
  6. AbsorbaTack $7,408 2 payments
  7. DAVINCI XI $3,000 1 payment
  8. Phasix Mesh $2,274 25 payments
  9. ARISTA $1,792 7 payments
  10. PHASIX BD Interventional Surgery $1,415 6 payments
  11. Other $3,432 48 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 71 billing codes

Paid by Medicare

$139,473

Medicare's payments for the services billed

Medicare patients

167

Average age 73

Services billed

507

80 women, 87 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 56%
Diabetes 35%
Ischemic heart disease 34%
Heart failure 25%
Atrial fibrillation 24%
Chronic kidney disease 22%
Depression 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,539 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record